Suhagra 50 mg names sildenafil; it is not a Viagra NDC

It is not a United States Viagra NDC. The recommended starting dose of sildenafil for most patients is 50 mg, used as needed about 1 hour before sexual activity. VIAGRA is supplied as blue, film-coated, rounded-diamond-shaped tablets. The dose may be increased to a maximum recommended dose of 100 mg or decreased to 25 mg. The maximum recommended dosing frequency is once per day. Sexual stimulation is required.

For most patients the recommended starting dose remains 50 mg. The dose may be increased to a maximum recommended dose of 100 mg.

Sildenafil is contraindicated in patients using any form of organic nitrate, either regularly or intermittently. Do not combine with other PDE5 inhibitors. Viagra is not indicated for women. VIAGRA may be taken anywhere from 30 minutes to 4 hours before sexual activity.

Both sildenafil and the metabolite have terminal half lives of about 4 hours. Most studies assessed the efficacy of VIAGRA approximately 60 minutes post dose. The pharmacokinetics of sildenafil are dose-proportional over the recommended dose range.

Adults 65 years of age and older may use 25 mg as a single dose no more than once a day. The recommended starting dose of sildenafil for most patients is 50 mg. The dose may be increased to a maximum recommended dose of 100 mg or decreased to 25 mg. The maximum recommended dosing frequency is once per day. Sexual stimulation is required.

VIAGRA is supplied as blue, film-coated, rounded-diamond-shaped tablets. VIAGRA tablets contain sildenafil citrate equivalent to 25 mg, 50 mg, or 100 mg of sildenafil. Suhagra 50 mg is not a United States Viagra NDC. Store at 25 C (77 F); excursions permitted to 15 to 30 C (59 to 86 F). Viagra is indicated for erectile dysfunction. Viagra is not indicated for women.

In fixed-dose studies, headache occurred in 21% at 50 mg versus 7% on placebo. Flushing occurred in 19% at 50 mg versus 2% on placebo. Dyspepsia occurred in 9% at 50 mg versus 2% on placebo. Abnormal vision occurred in 2% at 50 mg versus 1% on placebo. Nasal congestion occurred in 4% at 50 mg versus 2% on placebo. The most common adverse reactions reported in clinical trials (≥ 2%) are headache, flushing, dyspepsia, abnormal vision, nasal congestion, back pain, myalgia, nausea, dizziness, and rash.

The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues. Sildenafil and its major circulating N-desmethyl metabolite are both approximately 96% bound to plasma proteins. Both sildenafil and the metabolite have terminal half lives of about 4 hours. The pharmacokinetics of sildenafil are dose-proportional over the recommended dose range. It is not a United States Viagra NDC.

Maximum observed plasma concentrations are reached within 30 to 120 minutes (median 60 minutes) of oral dosing in the fasted state. When VIAGRA is taken with a high fat meal, the rate of absorption is reduced, with a mean delay in Tmax of 60 minutes. Both sildenafil and the metabolite have terminal half lives of about 4 hours. The recommended starting dose of sildenafil for most patients is 50 mg. Suhagra 50 mg is export foil. The maximum recommended dosing frequency is once per day.